Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
Biorxiv : the Preprint Server for Biology|November 1, 2024
Oncogenic Alterations, Race, and Survival in US Veterans with Metastatic Prostate Cancer Undergoing Somatic Tumor Next Generation SequencingLuca F Valle, Jiannong Li, Heena Desai, et al.
JAMA Network Open|May 12, 2025
Somatic Tumor Next-Generation Sequencing in US Veterans With Metastatic Prostate CancerLuca F Valle, Jiannong Li, Heena Desai, et al.
International Journal of Radiation Oncology, Biology, Physics|October 23, 2023
Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized TrialBeth K Neilsen, Ting Martin Ma, Wisdom O Akingbemi, et al.
European Urology Oncology|September 22, 2024
American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive RadiotherapyLuca F Valle, Tommy Jiang, Ashton Rosenbloom, et al.
Fungal Genetics and Biology : FG & B|September 24, 2022
Single nucleotide polymorphisms and chromosomal copy number variation may impact the Sporothrix brasiliensis antifungal susceptibility and sporotrichosis clinical outcomesMarcus M Teixeira, Rodrigo Almeida-Paes, Andréa R Bernardes-Engemann, et al.
Frontiers in Oncology|June 9, 2020
Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body RadiotherapyLuca F Valle, Dan Ruan, Audrey Dang, et al.
European Urology|November 13, 2024
Magnetic Resonance Imaging Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy in Prostate Cancer: 2-year Outcomes from the MIRAGE Randomized Clinical TrialAmar U Kishan, James M Lamb, Holly Wilhalme, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|January 11, 2018
Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapyLuca F Valle, Matthew D Greer, Joanna H Shih, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical ProstatectomyJohn Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
European Urology|December 14, 2020
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)Luca F Valle, Eric J Lehrer, Daniela Markovic, et al.
Pageof 25